Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



After 47% Gains in 2013, DuPont Looks Poised for Another Big Year

After ranking among the worst performers in the Dow Jones Industrials in 2012, DuPont (NYSE: DD  ) shares staged a solid comeback this year, returning a market-beating 47% year to date.

That also makes DuPont one of the best industry performers for 2013, hugely outperforming arch rival Monsanto's (NYSE: MON  ) 23% returns and second only to Huntsman Chemical's (NYSE: HUN  ) whopping 56% gains so far. Peer Dow Chemical (NYSE: DOW  ) is trying to play catch up, having jumped 15% this month alone, but the stock is still closing the year a notch below DuPont with 41% returns.

DD Total Return Price Chart

DD Total Return Price data by YCharts

So, did DuPont deliver solid growth on its top and bottom lines this year that peers couldn't match up? Not quite. In fact, the company is set to close the financial year on a dour note. Investors are simply optimistic about DuPont's prospects, backed by some major business decisions that it took in 2013.

DuPont's truce with Monsanto over a long-pending legal battle, and its decision to divest its core titanium dioxide pigment (TiO2) business soon after Huntsman Chemical made a similar announcement were the most notable developments. Encouraged by those business decisions, analysts expect DuPont's earnings to grow 13% in 2014. But will the company's moves really pay off and boost share prices in 2014, or have investors jumped the gun? Let's find out.

The big opportunity
DuPont's agriculture business was the strongest this year, contributing 35% and 48% to its total sales and operating income for the nine months ended Sept. 30, 2013. Seed sales grew 11% during the period, helping DuPont gain more than a percentage point share in the critical U.S. corn market. This year DuPont also acquired majority stake in one of South Africa's leading seed companies, Pannar Seed, thereby expanding its global presence.

But the most significant development of 2013 was the cross-licensing agreement that DuPont struck with Monsanto. In return for an annual royalty totaling $802 million to be paid for four years beginning 2014, and another annual payment of $950 million starting 2018, DuPont will be able to offer Monsanto's soybeans trait, including the popular Genuity Roundup Ready 2 Yield soybeans, from next year. While the financial implication is big, access to the world's largest seed company's technologies certainly has its advantages. The deal has come at an opportune time. With a record corn harvest this year sending corn prices to multiyear low, farmers in the U.S. gear up to plant more soybeans in 2014.

Backed by these additional opportunities, DuPont's agriculture business should continue to perform well next year. Meanwhile, if the TiO2 markets revive, DuPont's 2014 performance graph could end up looking way better than this year's.

Will this idea work?
Improving sales volumes in recent months signal a reviving Tio2 market. TiO2 was a high-margin product until late 2012 when a supply glut sent pigment prices tumbling. After a long lull, both DuPont and Huntsman Chemical reported 25% and 20% higher year-over-year TiO2 sales volumes, respectively, during their third quarter. That's encouraging news for DuPont going into 2014.

But all eyes will be on the progress of DuPont's planned TiO2 segment spin-off. The business, which generated $7.2 billion in revenue in 2012 and contributed 21% to the company's total revenue, will be spun off into a separate public company. Given the volatile and unpredictable nature of the TiO2 markets, DuPont expects the separation to unlock greater value for its shareholders. With industry experts remaining less hopeful about the TiO2 business over the long run, and Huntsman also opting to separate its pigment division, DuPont could be headed the right way.

At the same time, DuPont is well established as the world's largest TiO2 producer, while it still has a long way to go in the field of agriculture. Competition from Monsanto is intense, and there's the threat of getting mired in controversies over genetically modified organism foods. So separating the TiO2 business doesn't mean that it'll be a smooth ride from here. With DuPont planning to complete the transaction within the next 18 months, investors should expect significant progress and regular updates in 2014.

Solar power
DuPont's electronics and communications division should also improve in 2014. Revenue from the business fell 8% through September this year even as Dow Chemical reported 2% improvement in sales from its electronics and functional materials business during the period. While dominance in the smartphone and tablet material market is boosting Dow Chemical's revenue, DuPont's focus on photovoltaic and solar materials hasn't helped much. But with China planning to install 12 gigawatts of PV power next year, DuPont's prospects look better.

Foolish takeaway
With growth catalysts in place, DuPont should perform well in 2014. And if the company can capitalize on the Monsanto soybean opportunity, and completes the TiO2 transaction ahead of schedule, the stock could head even higher. DuPont investors can look forward to an eventful and profitable 2014. 

DuPont looks great, but this particular stock could land you with earth-shattering returns
Imagine a company that rents a very specific and valuable piece of machinery for $41,000... per hour (that's almost as much as the average American makes in a year!). And Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report reveals the company we're calling OPEC's Worst Nightmare. Just click HERE to uncover the name of this industry-leading stock... and join Buffett in his quest for a veritable LANDSLIDE of profits!


Read/Post Comments (3) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 26, 2013, at 3:34 PM, funfundvierzig wrote:

    In short, DuPont Management is tossing away DuPont's supreme position in TIO2, where it reigns as the the leader in TIO2 technology and largest producer in the world to concentrate nearly exclusively on its crown jewel, DuPont AG & NUT. Unfortunately, DuPont plays second fiddle on the world stage to Monsanto in seeds, to Syngenta in crop protection and to Novozymes in enzymes and food additives.

    Investors need to ask themselves whether they would be better off investing in Monsanto, the true biotech leader and superior innovator in seeds, or the copycat, DuPont, which pays out hundreds of $millions in license fees yearly to Monsanto in order to embed DuPont Pioneer's otherwise inferior seeds with Monsanto's GM traits.


  • Report this Comment On December 26, 2013, at 10:38 PM, szcz wrote:

    I thought that Funfun's bashing of DD was limited to Seeking Alpha (SA). In 2013, every positive article written on SA was immediately followed by a negative response from FunFun.

    However, it is clear from DD's 47% gain this year that Funfun cannot stop the upward trajectory of the stock price of DD.

  • Report this Comment On December 26, 2013, at 11:16 PM, funfundvierzig wrote:

    The long-term trajectory of DuPont's stock has been down over the course of the 21st century, after setting a peak of 84 and change over 15 years ago in May of 1998. For years, DuPont's PR-driven leaders have been tenaciously embracing a business model of SHRINKAGE equals GROWTH, promising growth and gains, but delivering little. Notwithstanding the personal heckling of hostile fans and supporters of DuPont Management, the undersigned will continue to share thoughts and opinions on this equity with fellow investors.

    DuPont Management commands a veritable army of PR agents, lobbyists, lawyers, IMAGE consultants and trade association operatives to propagandise and put forth public relations puffery. Surely a single voice of an independently-speaking individual investor with a differing perspective should be tolerated....funfun..

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2776498, ~/Articles/ArticleHandler.aspx, 9/29/2016 1:12:34 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:01 PM
DD $67.19 Down -0.07 -0.10%
DuPont CAPS Rating: ****
DOW $52.33 Up +0.22 +0.42%
The Dow Chemical C… CAPS Rating: ****
HUN $15.97 Up +0.44 +2.83%
Huntsman CAPS Rating: **
MON $102.56 Up +0.31 +0.30%
Monsanto CAPS Rating: ***